Navigation Links
PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
Date:12/10/2009

NASHVILLE, Tenn., Dec. 10 /PRNewswire/ -- PharmMD recently raised $8.8 million in capital from The Riverside Company and FCA Ventures IV, a fund of Clayton Associates.

A market leader in medication therapy management (MTM), PharmMD works with self-insured employers and health plans to improve patients' quality of life and to reduce overall healthcare costs by connecting the patient, physician and pharmacist together. MTM helps improve patient outcomes by guarding against medication error, misuse and overuse by identifying costly medication duplication and preventing harmful drug interactions.

"We are excited to accomplish another successful round of fundraising with a high-caliber partner like Riverside," said Bo Bartholomew, co-founder and CEO of PharmMD. "Right now there is a unique opportunity for growth in medication management. This new funding equips PharmMD to continue to expand the company. PharmMD will help more employers reduce their costs and allow health plans to achieve compliance with Centers for Medicare & Medicaid Service's new 2010 MTM Standards. As we continue to personalize healthcare, we are doing our part to ensure that more patients receive the medication they need, in the dosage they need, when they need it.

"As a leader in the MTM industry, PharmMD is poised to play an important role in pending healthcare reform. MTM services lower costs and improve healthcare, which is why the service is widely praised by industry experts and organizations," said Jeff Goodman, Operating Partner at The Riverside Company.

The PharmMD board of directors will remain in place with the addition of two new members from Riverside's team: Brian Sauer, Vice President for Riverside, and Goodman, who will also serve as the new chairman.

R. Clayton McWhorter, founder and chairman of Clayton Associates, will continue to serve on the PharmMD board and be an active advisor to the company. Other members of the PharmMD board include Craig Fuller, President and CEO of the Aircraft Owners and Pilots Association; Jim Lackey, chairman of the board for Passport Health Communications, Inc.; and Mike Kane, President of Kestrel Asset Fund.

Harpeth Capital advised PharmMD during this investment round. PharmMD is headquartered in Brentwood, Tenn. The company's web site can be accessed at www.PharmMD.com.

About PharmMD

PharmMD is the nation's leading MTM provider. Based in Brentwood, Tenn., PharmMD prevents medication related problems through the application of the best pharmacist and physician knowledge. Founded in 2006 and led by CEO and President Samuel 'Bo' Bartholomew III, PharmMD improves coordination and communication among physicians, pharmacists, payers and patients by analyzing pharmacy and medical claims information and clinical decision making. Because PharmMD focuses exclusively on MTM, the company is able to analyze both aggregate and patient-specific data to identify trends and conflicts to positively impact patient health and contain costs. For more information, visit www.PharmMD.com.

The Riverside Company

The Riverside Company is a global private equity firm focused on acquiring leading small and medium-sized enterprises (with a value of up to $150 million) and partnering with strong management teams to enhance the success of its companies through acquisitions and organic growth. Since its founding in 1988, the firm has invested in 221 transactions with a total enterprise value of $5.0 billion. The investment portfolio in North America, Europe and Asia includes 71 companies with annual sales totaling $3.3 billion, EBITDA of $506 million and more than 13,000 employees (June 2009). Riverside offers the resources to complete acquisitions smoothly - thanks to its more than $3.0 billion in assets under management, more than 180 professionals in 18 offices (Atlanta, Brussels, Budapest, Chicago, Cleveland, Dallas, Eindhoven, Hong Kong, Los Angeles, Madrid, Munich, New York, Prague, San Francisco, Seoul, Stockholm, Tokyo and Warsaw) and its longstanding relationships with partner lenders. According to Thomson Venture Economics, seven of Riverside's nine mature funds rank in the top 25% of all funds (as at 31 December 2008). The firm's investors include the world's leading pension funds, endowments, funds of funds, insurance companies and banks. For more information visit www.riversidecompany.com or www.riversideeurope.com.

About FCA Venture Partners IV

Clayton Associates is a private equity firm based in Franklin, Tennessee that invests in early stage growth companies and selected real estate ventures. FCA Venture Partners IV is their fourth fund. Clayton Associates has more than ten years of private equity experience, with over $100 million in committed capital in four funds. Clayton Associates invests primarily in healthcare related services and technology, but also considers other industries including technology, communications, diversified services, health sciences, and biotechnology.

About Harpeth Capital

Harpeth Capital is a middle market focused investment bank that specializes in raising capital and providing merger and acquisition advisory services to both public and private companies. Harpeth Capital is a wholly owned subsidiary of Harpeth Companies, Inc., a diversified financial services firm. In addition to investment banking, Harpeth Companies has activities under Harpeth Consulting, Harpeth Ventures and Harpeth Real Estate. You can learn more about Harpeth Capital and Harpeth Companies at www.harpethcapital.com.

SOURCE PharmMD


'/>"/>
SOURCE PharmMD
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. PharmMD Expands Advisory Board
2. PharmMD Announces Denise Kehoe as Vice President of Business Development
3. PharmMDs Brad Tice Named APhA Fellow
4. PharmMD Becomes an ASCP MTM Provider Partner
5. Independence Blue Cross Secures All-Blue Contract with Lincoln Financial Group
6. Raphaelson & Levine Secures $1.1 Million Verdict for Victim of New York Construction Accident
7. Blue Sky Scrubs Secures a Second Texas Manufacturer
8. Duffy & Duffy Secures $3.1 Million Verdict in Nassau Supreme Court
9. The Ensign Group Secures $40 Million Loan From GE Capital, Healthcare Financial Services
10. AcceleDent System From OrthoAccel Technologies, Inc. Secures Medical Device Regulatory Clearance to Market in Australia
11. Leahy Secures Funds to Support Adoption of Electronic Prescribing in Vermont
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... ... 2017 , ... Anesthesia Progress – Everyone wants less pain during ... option for each patient. Dentists have several general anesthesia alternatives and finding the right ... the Tokyo Dental College in Tokyo, Japan wanted to find out which anesthetic was ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... Healthful-Flex. , The company, owned and operated by Ed Stroup, was created ... reasonable price with the highest level of customer service. Healthful Balance products can ...
(Date:1/17/2017)... Clemente, CA (PRWEB) , ... January 17, 2017 ... ... Diego County, as well as Palm Desert, is opening a new office in ... Brainsway deep transcranial magnetic stimulation (dTMS) in Southern California, successfully treating individuals struggling ...
(Date:1/17/2017)... ... 2017 , ... A prescription medication bottle, pocket knife, luggage and a solar-powered ... Product Design Challenge , the Cradle to Cradle Products Innovation Institute has ... scheduled to run through early 2018. The challenges are presented by the Institute in ...
(Date:1/17/2017)... CA (PRWEB) , ... January 17, 2017 , ... Livionex, ... the results of a double blind clinical study for its dental gel that shows ... leading national brand of toothpaste containing triclosan. The study was conducted at the Beckman ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... 17, 2017  Zimmer Biomet Holdings, Inc. (NYSE and ... today announced that it has implemented a ... the Zimmer Biomet management team. Effective January 23, ... the position of President, Americas and join the ... served as Zimmer Biomet,s Vice President of U.S. ...
(Date:1/17/2017)... Research and Markets has announced the addition of the ... ... laparotomy sponges market to grow at a CAGR of 7.94% during ... 2016-2020, has been prepared based on an in-depth market analysis with ... its growth prospects over the coming years. The report also includes ...
(Date:1/17/2017)... BELLEFONTE, Pa. , Jan. 17, 2017 /PRNewswire/ ... Medical, Inc.(AMI) announces the addition of 6 senior ... of the TubeClear® System.  These sales leaders were ... recently acquired medical device company. Repeatedly recognized for ... of exceeding customer expectations and establishing relationships with ...
Breaking Medicine Technology: